{"id":79,"date":"2021-09-20T12:57:41","date_gmt":"2021-09-20T12:57:41","guid":{"rendered":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/dr-juan-manuel-o-connor\/"},"modified":"2023-06-14T13:01:55","modified_gmt":"2023-06-14T11:01:55","slug":"dr-juan-manuel-o-connor","status":"publish","type":"experts","link":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/dr-juan-manuel-o-connor\/","title":{"rendered":"Dr Juan Manuel O&#8217;Connor"},"content":{"rendered":"<p>Dr Juan Manuel O\u2019Connor is currently Head of the Department of Gastrointestinal Tumors at Instituto Alexander Fleming, a position he has held since 2015. He is Assistant Professor of Clinical Pharmacology at the School of Medicine of the Instituto Universitario CEMIC, Buenos Aires. He is a founding member of the Argentine Group of Neuroendocrine Tumors (ARGENTUM), created in 2005. Dr O\u00b4Connor is a member of the Argentinian Intergroup of Gastrointestinal Tumors (IATTGI), and also of the recently created Latin American Society for Gastrointestinal Tumors, chaired by Dr Jorge Gallardo. He has been a member of the Advisory Board of the European Society of Neuroendocrine Tumors, ENETS since 2008, and an active member of ASCO since 2011. He finished his fellowship in Clinical Oncology in 2003, held at the Alexander Fleming Institute, affiliated to the University of Buenos Aires, rating with Cum Laude10\/10. Dr O\u00b4Connor has authored over 50 papers and chapters of books about gastrointestinal tumors. He received several international awards for his work in the area of \u200b\u200bneuroendocrine tumors. He has participated in more than 200 national and international events as a speaker. Dr O\u00b4Connor also served as a consultant to the National Cancer Institute in Argentina, and was involved in the development of the Clinical Practice Guidelines in Metastatic Colorectal Cancer in Argentina, in 2014.<\/p>\n","protected":false},"author":{"id":1,"first_name":"Francisco","nickname":"Superadmin","email":"jose.santos@cor2ed.com"},"featured_media":78,"menu_order":184,"template":"","groups":[],"class_list":["post-79","experts","type-experts","status-publish","has-post-thumbnail","hentry"],"expert_info_prefix":"Dr","expert_info_first-name":"Juan Manuel","expert_info_last-name":"O'Connor","expert_info_institution":"Instituto Alexander Fleming","expert_info_country":"AR","expert_info_specialization":"Medical Oncologist","expert_info_map-code":"","expert_info_disclosures":"<p>Merck, MSD, BMS, Servier, Ipsen, Sanofi, Pfizer<\/p>","expert_info_linkedin":"","expert_info_twitter":"","expert_info_instagram":"","expert_info_facebook":"","_links":{"self":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/79","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts"}],"about":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/types\/experts"}],"version-history":[{"count":4,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/79\/revisions"}],"predecessor-version":[{"id":89089,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/79\/revisions\/89089"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media\/78"}],"wp:attachment":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media?parent=79"}],"wp:term":[{"taxonomy":"groups","embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/groups?post=79"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}